I
Iacopo Olivotto
Researcher at University of Florence
Publications - 465
Citations - 22039
Iacopo Olivotto is an academic researcher from University of Florence. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Medicine. The author has an hindex of 59, co-authored 339 publications receiving 17160 citations. Previous affiliations of Iacopo Olivotto include Brigham and Women's Hospital & University of Perugia.
Papers
More filters
Journal ArticleDOI
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
Martin S. Maron,Iacopo Olivotto,Sandro Betocchi,Susan A. Casey,John R. Lesser,Maria A. Losi,Franco Cecchi,Barry J. Maron +7 more
TL;DR: In patients with hypertrophic cardiomyopathy, left ventricular outflow tract obstruction at rest is a strong, independent predictor of progression to severe symptoms of heart failure and of death.
Journal ArticleDOI
Short-Term Clinical Outcome of Patients With Acute Pulmonary Embolism, Normal Blood Pressure, and Echocardiographic Right Ventricular Dysfunction
Stefano Grifoni,Iacopo Olivotto,Paolo Cecchini,Filippo Pieralli,Alberto Camaiti,Gennaro Santoro,A. Conti,Giancarlo Agnelli,Giancarlo Berni +8 more
TL;DR: A significant proportion of normotensive patients with acute PE presents with RV dysfunction; these patients with latent hemodynamic impairment have a 10% rate of PE-related shock and 5% in-hospital mortality and may require aggressive therapeutic strategies.
Journal ArticleDOI
Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
Martin S. Maron,Iacopo Olivotto,Andrey G. Zenovich,Mark S. Link,Natesa G. Pandian,Jeffery T. Kuvin,Stefano Nistri,Franco Cecchi,James E. Udelson,Barry J. Maron +9 more
TL;DR: Identification of LV outflow obstruction with exercise echocardiography may broaden management options in HCM by identifying symptomatic patients not otherwise regarded as potential candidates for septal reduction therapy.
Journal ArticleDOI
Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.
Barry J. Maron,Iacopo Olivotto,Paolo Spirito,Susan A. Casey,Pietro Bellone,Thomas E. Gohman,Kevin J. Graham,David A. Burton,Franco Cecchi +8 more
TL;DR: This revised clinical profile suggests that generally held epidemiological tenants for HCM have been influenced considerably by skewed reporting from highly selected populations and are likely to importantly affect risk stratification and treatment strategies importantly for the prevention of sudden death in HCM.
Journal ArticleDOI
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
Raymond H. Chan,Barry J. Maron,Iacopo Olivotto,Michael J. Pencina,Gabriele Egidy Assenza,Tammy S. Haas,John R. Lesser,Christiane Gruner,Andrew M. Crean,Harry Rakowski,James E. Udelson,Ethan J. Rowin,Massimo Lombardi,Franco Cecchi,Benedetta Tomberli,Paolo Spirito,Francesco Formisano,Elena Biagini,Claudio Rapezzi,Carlo N. De Cecco,Camillo Autore,E. Francis Cook,Susie N. Hong,C. Michael Gibson,Warren J. Manning,Evan Appelbaum,Martin S. Maron +26 more
TL;DR: Extensive LGE measured by quantitative contrast enhanced CMR provides additional information for assessing SCD event risk among HCM patients, particularly patients otherwise judged to be at low risk.